GREM1 and ductal breast carcinoma in situ: Of note, GREM1 was one of eight elevated genes shown in cancer cells laser-dissected from invasive breast carcinoma patients compared with cancer cells from ductal carcinoma in situ patients [48], supporting that GREM1 could be expressed by the transformed cancer cells themselves and associated with an invasive phenotype.